{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:52:16Z","timestamp":1781646736071,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["333925"],"award-info":[{"award-number":["333925"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["333925"],"award-info":[{"award-number":["333925"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["333925"],"award-info":[{"award-number":["333925"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["333925"],"award-info":[{"award-number":["333925"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly, and early detection is essential for timely intervention and slowing disease progression. This study validated novel foveal function tests using the Bulbicam (BCAM) device for differentiating early and intermediate dry AMD from healthy controls (HCs) and to identify functional variables that may serve as candidate biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a controlled clinical study, 17 patients with early and intermediate dry AMD and 17 age-matched HCs were assessed using the proprietary Bulbitech \u201cACOLAPT\u201d (Acuity, Contrast, Light Adaptation) test. Each eye was classified as either the \u201cWorst eye\u201d or \u201cBest eye\u201d for AMD patients based on predefined clinical criteria. Foveal function metrics were derived from the five main variables: Pursuit acuity (PuAc), Pursuit contrast sensitivity (PuCS), Strobe Pursuit Contrast Sensitivity(StCS), (PuCS\u2009\u2212\u2009StCS) \/ PuCS (\u0394CS), and Variable Strobe Pursuit Object Detection(VaSt). Test validity, reliability, repeatability, and stability were assessed. Validation of ACOLAPT included Analysis of Variance (ANOVA) and Receiver Operating Characteristic (ROC) analyses to assess discriminative capacity, intraclass correlation coefficients (ICC) and Bland-Altman plots with Agreement Index (AI) to evaluate reliability and Stability Index (SI) for estimation of stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All five BCAM tests showed significant differences between AMD patients and HCs in the worst eye (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.05). PuAc and PuCS showed good reliability (ICC\u2009\u2265\u20090.77), good repeatability (AI\u2009\u2265\u20090.75), and excellent stability (SI\u2009\u2265\u20090.59). The novel StCS test demonstrated excellent reliability (ICC\u2009=\u20090.96), excellent repeatability (AI\u2009=\u20090.88), and excellent stability (SI\u2009=\u20090.58). Despite good ICC values, VaSt and \u0394CS had lower repeatability (AI\u2009\u2264\u20090.25), highlighting the importance of AI and SI metrics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PuAc, PuCS, and StCS fulfilled the predefined criteria for reliability, repeatability, and stability, supporting their use as candidate biomarkers at both population and individual patient levels. VaSt also met the predefined biomarker criteria through preserved cross-session stability despite lower single-trial agreement. ACOLAPT\u2019s ability to assess multiple aspects of foveal function, along with enhanced stability and repeatability metrics, suggests that it could be valuable in clinical settings for early AMD detection and monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00838-x","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:55:15Z","timestamp":1774572915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eye-tracking-derived foveal biomarkers and functional alterations in dry AMD: findings from a controlled clinical study"],"prefix":"10.1186","volume":"12","author":[{"given":"Bj\u00f8rn Andr\u00e9","family":"Helland-Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sverstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Petrovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig Einride","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"838_CR1","first-page":"e144","volume":"9","author":"RRA Bourne","year":"2020","unstructured":"Bourne RRA, Steinmetz JD, Saylan M, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2020;9:e144.","journal-title":"Lancet Glob Health"},{"key":"838_CR2","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728\u201338.","journal-title":"Lancet"},{"key":"838_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","volume":"75","author":"J Ambati","year":"2012","unstructured":"Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration. Neuron. 2012;75:26\u201339.","journal-title":"Neuron"},{"key":"838_CR4","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1167\/iovs.05-0767","volume":"46","author":"PT Johnson","year":"2005","unstructured":"Johnson PT, Brown MN, Pulliam BC, Anderson DH, Johnson LV. Synaptic Pathology, Altered Gene Expression, and Degeneration in Photoreceptors Impacted by Drusen. Invest Ophthalmol Vis Sci. 2005;46:4788\u201395.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"838_CR5","first-page":"1609","volume":"31","author":"RF Spaide","year":"2011","unstructured":"Spaide RF, Curcio CA, ANATOMICAL CORRELATES TO THE BANDS SEEN IN THE OUTER RETINA BY OPTICAL COHERENCE TOMOGRAPHY. Literature Rev Model Retina. 2011;31:1609.","journal-title":"Literature Rev Model Retina"},{"key":"838_CR6","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1167\/iovs.05-0767","volume":"46","author":"PT Johnson","year":"2005","unstructured":"Johnson PT, Brown MN, Pulliam BC, Anderson DH, Johnson LV. Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen. Invest Ophthalmol Vis Sci. 2005;46:4788\u201395.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"838_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.survophthal.2025.01.009","volume":"70","author":"C \u0162urca\u015f","year":"2025","unstructured":"\u0162urca\u015f C, Nicoar\u0103 SD. A comprehensive review of structure-function correlations in age-related macular degeneration: Contributions of microperimetry. Surv Ophthalmol. 2025;70:426\u201350.","journal-title":"Surv Ophthalmol"},{"key":"838_CR8","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.visres.2008.04.008","volume":"48","author":"H Sun","year":"2008","unstructured":"Sun H, Swanson WH, Arvidson B, Dul MW. Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma. Vis Res. 2008;48:2633\u201341.","journal-title":"Vis Res"},{"key":"838_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/11.5.7","volume":"11","author":"J Pokorny","year":"2011","unstructured":"Pokorny J. Review: Steady and pulsed pedestals, the how and why of post-receptoral pathway separation. J Vis. 2011;11:7\u20137.","journal-title":"J Vis"},{"key":"838_CR10","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1523\/JNEUROSCI.4610-06.2007","volume":"27","author":"DL Beaudoin","year":"2007","unstructured":"Beaudoin DL, Borghuis BG, Demb JB. Cellular basis for contrast gain control over the receptive field center of mammalian retinal ganglion cells. J Neurosci. 2007;27:2636\u201345.","journal-title":"J Neurosci"},{"key":"838_CR11","doi-asserted-by":"publisher","DOI":"10.1167\/18.5.13","author":"M Lucassen","year":"2018","unstructured":"Lucassen M, Lambooij M, Sekulovski D, Vogels I. Spatio-chromatic sensitivity explained by post-receptoral contrast. J Vis. 2018. https:\/\/doi.org\/10.1167\/18.5.13.","journal-title":"J Vis"},{"key":"838_CR12","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1007\/s40123-023-00807-9","volume":"12","author":"EM Lad","year":"2023","unstructured":"Lad EM, Finger RP, Guymer R. Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration. Ophthalmol Ther. 2023;12:2917.","journal-title":"Ophthalmol Ther"},{"key":"838_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature06150","volume":"449","author":"FA Dunn","year":"2007","unstructured":"Dunn FA, Lankheet MJ, Rieke F. Light adaptation in cone vision involves switching between receptor and post-receptor sites. Nature. 2007;449:603\u20136.","journal-title":"Nature"},{"key":"838_CR14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1167\/iovs.13-13745","volume":"55","author":"GR Jackson","year":"2014","unstructured":"Jackson GR, Scott IU, Kim IK, Quillen DA, Iannaccone A, Edwards JG. Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55:1427\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"838_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.10.12.14","volume":"10","author":"RH Guymer","year":"2021","unstructured":"Guymer RH, Tan RS, Luu CD. Comparison of Visual Function Tests in Intermediate Age-Related Macular Degeneration. Transl Vis Sci Technol. 2021;10:14.","journal-title":"Transl Vis Sci Technol"},{"key":"838_CR16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1001\/jamaophthalmol.2016.1535","volume":"134","author":"E Pilotto","year":"2016","unstructured":"Pilotto E, Convento E, Guidolin F, Abalsamo CK, Longhin E, Parrozzani R, Midena E. Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography. JAMA Ophthalmol. 2016;134:873.","journal-title":"JAMA Ophthalmol"},{"key":"838_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00417-016-3466-z","volume":"255","author":"S Vujosevic","year":"2017","unstructured":"Vujosevic S, Pucci P, Casciano M, Longhin E, Convento E, Bini S, Midena E. Long-term longitudinal modifications in mesopic microperimetry in early and intermediate age-related macular degeneration. Graefe\u2019s Archive Clin Experimental Ophthalmol. 2017;255:301\u20139.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"key":"838_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15:155\u201363.","journal-title":"J Chiropr Med"},{"key":"838_CR19","unstructured":"Pugh EN, Lamb TD. Phototransduction in vertebrate rods and cones molecular mechanisms of amplification, recovery and light adaptation."},{"key":"838_CR20","unstructured":"National Institute for Health and Care Excellence (NICE). (2018) Age-related macular degeneration: diagnosis and management. London."},{"key":"838_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0896-1549(03)00003-8","volume":"16","author":"C Owsley","year":"2003","unstructured":"Owsley C. Contrast sensitivity. Ophthalmol Clin North Am. 2003;16:171\u20137.","journal-title":"Ophthalmol Clin North Am"},{"key":"838_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.visres.2013.04.015","volume":"90","author":"DG Pelli","year":"2013","unstructured":"Pelli DG, Bex P. Measuring contrast sensitivity. Vis Res. 2013;90:10\u20134.","journal-title":"Vis Res"},{"key":"838_CR23","unstructured":"Rosser DA, Laidlaw AH. Murdoch IE. The development of a reduced logMAR visual acuity chart for use in routine clinical practice."},{"key":"838_CR24","first-page":"557","volume":"38","author":"GS Rubin","year":"1997","unstructured":"Rubin GS, West SK, SEE Project Team. A Comprehensive Assessment of Visual Impairment in a Population of Older Americans. Invest Ophthalmol Vis Sci. 1997;38:557\u201368.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"838_CR25","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.ajo.2011.05.021","volume":"152","author":"A Wood","year":"2011","unstructured":"Wood A, Binns A, Margrain T, Drexler W, Pova\u017eay B, Esmaeelpour M, Sheen N. Retinal and Choroidal Thickness in Early Age-Related Macular Degeneration. Am J Ophthalmol. 2011;152:1030\u2013e10382.","journal-title":"Am J Ophthalmol"},{"key":"838_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.1009599","author":"JHC Wong","year":"2022","unstructured":"Wong JHC, Ma JYW, Jobling AI, Brandli A, Greferath U, Fletcher EL, Vessey KA. Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system. Front Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnins.2022.1009599.","journal-title":"Front Neurosci"},{"key":"838_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/02713683.2015.1011282","volume":"41","author":"C Owsley","year":"2016","unstructured":"Owsley C, Huisingh C, Clark ME, Jackson GR, McGwin G. Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular Health. Curr Eye Res. 2016;41:266\u201372.","journal-title":"Curr Eye Res"},{"key":"838_CR28","unstructured":"Gillespie-Gallery H. Spatial and temporal aspects of visual performance in relation to light level and normal aging."}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00838-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:57:23Z","timestamp":1781643443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00838-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00838-x","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Decalrations"}},{"value":"Ethical review and approval were not required for this study on human participants under local legislation and institutional requirements. The study was reviewed by the data protection officer at Oslo University Hospital and submitted to the Regional Committee for Medical and Health Research Ethics (REK), which confirmed that formal ethical approval was not necessary. All participants provided written informed consent prior to participation. The study was conducted in accordance with institutional guidelines and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Bj\u00f8rn A. Helland-Hansen is currently employed as Chief Medical Officer at Bulbitech AS, and owns shares, as well as IP (patent: US20240335111A1 \u2013 \u201cEye Testing Device\u201d).Goran Petrovski serves on the Advisory Board of Bulbitech AS on a pro bono basis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}